olfactory receptor family 13 subfamily D member 3 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR13D3P profile across patient tissues and cancer cell-line models. OR13D3P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in OV. Among the 18 cancer types available for tumor–normal comparison, OR13D3P is differentially expressed in 2, with the highest sampling consensus in KIRC. Additionally, OR13D3P RNA expression shows 8,467 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight OV, KIRC, and LSCC as cancer lineages where OR13D3P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR13D3P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR13D3P survival associations across molecular data types. OR13D3P RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR13D3P RNA expression–survival associations across cancer types. High OR13D3P expression shows unfavorable associations in BLCA, COAD, KIRP and BRCA, but favorable associations in OV and LIHC. The OV Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .007). Together, the overview and detailed table identify OV as the clearest survival context for OR13D3P RNA expression.
This table summarizes OR13D3P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for OR13D3P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR13D3P shows lower tumor expression in KIRC and higher tumor expression in BRCA. The KIRC box plot shows higher OR13D3P RNA expression in normal versus tumor tissue (log2 FC = −0.016, t-test p = .008).
This table shows molecular features associated with OR13D3P in patient tissues and cancer cell lines. In patient samples, OR13D3P shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
